PF-Atlas › Clinical Trials › NCT04720443
A Safety, Tolerability, and Pharmacokinetic Study of NIP292 in Healthy Normal Subjects
NIP292 tablet · Phase 1
Registry ID
NCT04720443
Phase
Phase 1
Status
Completed
Drug / intervention
NIP292 tablet
Sponsor
The National Institutes of Pharmaceutical R&D Co. Ltd, China
Start
2019-11-22
Enrollment
56
Locations
1
About this trial
This study is being conducted to evaluate the safety and tolerability of single ascending and multiple ascending oral doses of NIP292 tablets administered following an overnight fast in healthy adult subjects.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT04720443 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.